ENTX
Price
$1.97
Change
+$0.06 (+3.14%)
Updated
May 22, 03:53 PM (EDT)
Capitalization
86.81M
77 days until earnings call
JSPR
Price
$4.85
Change
+$0.03 (+0.62%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
72.41M
Interact to see
Advertisement

ENTX vs JSPR

Header iconENTX vs JSPR Comparison
Open Charts ENTX vs JSPRBanner chart's image
Entera Bio
Price$1.97
Change+$0.06 (+3.14%)
Volume$100
Capitalization86.81M
Jasper Therapeutics
Price$4.85
Change+$0.03 (+0.62%)
Volume$1.57K
Capitalization72.41M
ENTX vs JSPR Comparison Chart
Loading...
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTX vs. JSPR commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTX is a Hold and JSPR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (ENTX: $1.91 vs. JSPR: $4.82)
Brand notoriety: ENTX and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTX: 174% vs. JSPR: 108%
Market capitalization -- ENTX: $86.81M vs. JSPR: $72.41M
ENTX [@Biotechnology] is valued at $86.81M. JSPR’s [@Biotechnology] market capitalization is $72.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTX’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • ENTX’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than ENTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTX’s TA Score shows that 5 TA indicator(s) are bullish while JSPR’s TA Score has 6 bullish TA indicator(s).

  • ENTX’s TA Score: 5 bullish, 6 bearish.
  • JSPR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, JSPR is a better buy in the short-term than ENTX.

Price Growth

ENTX (@Biotechnology) experienced а -3.54% price change this week, while JSPR (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

ENTX is expected to report earnings on Aug 08, 2025.

JSPR is expected to report earnings on Feb 28, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ENTX($86.8M) has a higher market cap than JSPR($72.4M). ENTX YTD gains are higher at: -9.906 vs. JSPR (-77.456). ENTX has higher annual earnings (EBITDA): -9.16M vs. JSPR (-74.87M). JSPR has more cash in the bank: 71.6M vs. ENTX (6.92M). ENTX has less debt than JSPR: ENTX (309K) vs JSPR (1.81M). ENTX has higher revenues than JSPR: ENTX (99K) vs JSPR (0).
ENTXJSPRENTX / JSPR
Capitalization86.8M72.4M120%
EBITDA-9.16M-74.87M12%
Gain YTD-9.906-77.45613%
P/E RatioN/AN/A-
Revenue99K0-
Total Cash6.92M71.6M10%
Total Debt309K1.81M17%
FUNDAMENTALS RATINGS
ENTX: Fundamental Ratings
ENTX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTXJSPR
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 16 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACN317.72-2.46
-0.77%
Accenture PLC
THRM27.00-0.34
-1.24%
Gentherm
BBW40.50-1.12
-2.69%
Build-A-Bear Workshop
DAR31.50-2.32
-6.86%
Darling Ingredients
VTGN2.43-0.20
-7.60%
VistaGen Therapeutics

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-4.37%
AUPH - JSPR
44%
Loosely correlated
+0.48%
ATNF - JSPR
38%
Loosely correlated
-8.70%
AVXL - JSPR
38%
Loosely correlated
+3.32%
ABCL - JSPR
36%
Loosely correlated
-4.78%
ABOS - JSPR
36%
Loosely correlated
-1.89%
More